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Parameters derived by ultrasonic myocardial characterization in
dialysis patients are associated with mortality
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Parameters derived by ultrasonic myocardial characterization
in dialysis patients are associated with mortality.
Background. Autopsy studies have shown that hypertrophic
hearts of uremic patients have peculiar characteristics. Changes
in tissue structure are detectable by ultrasound as changes in
echo reflectivity.
Methods. We studied 96 dialysis patients, 18 hypertensive
subjects with normal renal function and 52 healthy subjects.
The echo pattern of interventricular septum was assessed by
videodensitometry (VDT) (i.e., a computer-assisted quantita-
tive analysis of gray levels). For each pixel a numerical value
from 0 (black) to 255 (white) was assigned. From the resulting
histogram of gray level frequency distribution, we obtained in-
dexes of central tendency (reflectivity) and of homogeneity of
distribution (uniformity).
Results. For the same septum thickness, dialysis patients
showed a significantly greater reflectivity (87 ± 19 and 70 ± 17)
(P < 0.001) and lower uniformity (137 ± 32 and 184 ± 71) (P
< 0.007) compared with hypertensives. Hypertensive patients
showed VDT parameters similar to control subjects in spite of
significantly higher septum thickness (P < 0.003). Followed up
after 5 years, dialysis patients with a reduced homogeneity of
distribution of gray levels (lower uniformity) showed a signifi-
cantly shorter survival (HR by Cox 2.5, 95% CI 1.21-5.27).
Conclusion. For a similar degree of cardiac hypertrophy, dial-
ysis patients differed widely from hypertensives in their VDT
parameters. By contrast, the hypertensive heart differed from
the normal heart in the degree of hypertrophy but not in terms
of VDT parameters. VDT parameters are independent predic-
tors of all-cause mortality in dialysis patients.
Left ventricular hypertrophy (LVH), the most frequent
cardiac alteration on patients in chronic hemodialysis [1–
3], is an independent risk factor for survival [1, 4, 5].
Few studies suggest that not only the cardiac mass per
se, but also the type of geometric patterns of remodeling,
has an impact on survival [6, 7].
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In the uremic heart some characteristics are found mi-
croscopically that are overexpressed in comparison with
other types of LVH. In fact, increased volume density
of interstitial tissue with reduced capillary density has
been described in experimental studies [8] and a nonre-
placement type of interstitial fibrosis was found in uremic
patients to be more marked than in subjects with pri-
mary hypertension [9]. Moreover, deposition of calcium
salts [10] and sometimes amyloids [11] have also been
described in uremic patients.
Changes in cardiac tissue structure resulting from mor-
bid processes can be detected by ultrasound as a change in
echo reflectance [12]. It has been suggested that echocar-
diographic tissue analysis may be clinically useful in vari-
ous types of cardiac pathology [13–17], including uremic
cardiopathy [18–26].
Extending our previous experience [24–26], in this
study we hoped to determine whether echocardiographic
tissue analysis is capable of (1) capturing in vivo differ-
ences in the echo signal of the hypertrophic myocardium
of uremic subjects in comparison with the hypertrophic
myocardium of subjects with arterial hypertension and
normal renal function; and (2) whether the ultrasonic al-
terations of the hypertrophic uremic myocardium are in-
dependent risk factors for survival.
METHODS
We studied an overall total of 166 subjects subdivided
as follows: 96 uremic patients in hemodialytic treatment
for 61 ± 45 months, 18 hypertensive subjects with normal
renal function, and 52 healthy subjects. The hypertensive
subjects were recruited from our outpatient clinics, the
controls were chosen among hospital medical and nursing
staff.
The characteristics of the population analyzed are de-
scribed in Table 1.
The 96 dialysis patients represent 62% of the patients
in hemodialytic treatment in our unit, excluding patients
with an inadequate acoustic window for the echo, or with
paradox movements of the septum as an expression of
infarctual areas in that location, or with a dialysis vintage
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Table 1. Subject characteristics
Male/ Age Body
Number female years surface m2
Controls 52 37/15 48.3 ± 15.4 1.84 ±.19
Hypertensives 18 6/12 52.0 ± 14.3 1.82 ± .15
Dialysis patients 96 55/41 60.0 ± 14.2a 1.69 ± .18b
Total 166 98/68
aP < 0.001 vs. controls; bP < 0.001 vs. controls and hypertensives.
lower than or equal to 3 months. Prevalence of their car-
diovascular comorbidity was as follows: seven with di-
abetes, 18 with myocardial infarctions, 24 with chronic
heart failure, seven with arrhythmias, and 12 strokes.
Their predialysis blood pressure values were 145 ± 79
mm Hg, on average; almost half of them, 45 out of 96,
were on antihypertensive treatment; interdialytic body
weight increase was 2.5 ± 0.8 kg. Predialysis hemoglobin
was 10.5 ± 1.8 g/dL, intact parathyroid hormone (iPTH)
239 ± 253 pg/mL, and urea reduction rate 72% ± 6%.
Bidimensional echocardiography was performed with
an echocardiograph with a 2.5 MHz electronic transducer
(SIM 7000; CFM, Esaote, Genoa, Italy). Dialysis patients
were examined 30 minutes after the end of the dialytic
session. Left ventricular mass indexed for body surface
area was calculated using the Penn cube formula. Tis-
sue analysis was performed by means of videodensito-
metry (VDT), that is, an analysis of gray levels in the
ultrasound images. Details of the technique were de-
scribed in our earlier papers [25, 26] and are summarized
here. After conventional echocardiographic examination
was completed, an echocardiographic examination with
preset and standardized parameters was performed. The
echocardiographic image obtained in the four-chamber
mode and corresponding to the telediastolic phase of
the cardiac cycle was selected and digitized by an im-
age processing computer (Mipron; Kontron, Muenchen,
Germany) and transformed into a pixel matrix (256 ×
256) with a gray level numerical value for every individ-
ual pixel ranging from 0 (black) to 255 (white).
For a first-order statistical analysis (i.e., without consid-
ering spatial interdependencies), a region was selected,
measuring about 9 × 9 pixels, within the central part of
the interventricular septum (IVS), with particular care
being taken to exclude hyperreflective areas like the en-
docardium. From the matrix of values thus obtained, a
histogram of the distribution frequency of grays was con-
structed. First-order statistics provide a large variety of
parameters for the quantitative description of the shape
of the histogram of the gray level amplitude (tonal) dis-
tribution of the selected region of interest. The mathe-
matical formulas relative to those parameters are given
in the Appendix. The parameters we used to describe
the histogram are the following: (1) reflectivity, or mean,
quantifies the average amplitude of the echographic re-
0 > 255 0 > 255
Fig. 1. A representative histogram of frequency distribution of gray
levels (lower panel) derived by echocardiographic images of interven-
tricular septum (upper panel) in a dialysis patient (left) and in a normal
subject (right). In comparison to normal, uremic heart appears more
brilliant and this is heralded by a higher reflectivity. Histogram is more
scattered (lower uniformity).
sponse and represents the gray level around which the
image is developed; and (2) uniformity, or tonal homo-
geneity, evaluates whether the pixels are clustered around
a defined gray level. Mathematically, it is the summation
of the single probabilities.
In a preceding study [25] we tested the reproducibility
of such parameters by analyzing paired data obtained
from two different samplings, from 1 to 3 months distant
from each other; we found an error less than 3% and 9%
for reflectivity and uniformity, respectively.
Figure 1 shows a representative picture of VDT anal-
ysis. In comparison with the septum of a normal subject,
the septum of a dialysis patient appears more brilliant
and this is associated with an increasingly less clustered
frequency histogram more distributed toward the white.
For the dialysis patients, we extracted from our com-
puterized clinical records data on previous cardiac events
and peripheral vascular events. Cardiac events were de-
fined as a clinically evident and instrumentally docu-
mented myocardial infarct and/or ischemic cardiopathy;
peripheral vascular events as amputation or the pres-
ence of clinically evident claudicatio intermittens always
associated with instrumentally (arteriography and/or
Doppler) documented peripheral arteriopathy. Dialysis
patient survival was tracked following VDT analysis.
Values are expressed as mean ± SD. For statistics we
used the SPSS statistical package. Analysis of variance
(ANOVA) with Bonferroni post hoc test for multiple
comparisons, multivariate analysis, simple correlations,
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Table 2. Parameters from conventional echocardiography and
videodensitometry
Interventricular Uniformity
septum mm Reflectivity (×1000)
Controls 9.3 ± 0.9 72.1 ± 15.3 184.5 ± 86.1
P value 0.003 NS NS
Hypertensives 11.0 ± 1.6 69.9 ± 16.9 183.8 ± 71.1
P value NS 0.001 0.007
Dialysis patients 11.8 ± 2.2 86.9 ± 19.1 137.3 ± 32.5
and linear regression were employed when appropriate.
Using regular Cox proportional hazards regression anal-
ysis we compared the mortality risk of hemodialysis pa-
tients according to whether their VDT parameters were
above or below the median with adjustment for potential
confounders. Covariates for adjustment include age at
study entry, previous cardiac and/or vascular events, and
left ventricular mass index. Number of covariates was se-
lected according to the events observed (e.g., 1 covariate
every 10 events). Patient survival times were recorded at
event occurrence (all-cause mortality), loss to follow-up,
or at the follow-up end, whichever came first.
RESULTS
Table 2 summarizes the echocardiographic results of
interest for this study. Thickness of the IVS (i.e., the lo-
cation of VDT parameter sampling) was not significantly
different in dialysis patients and hypertensives, even if
the values are numerically lower in the latter. Values
in both groups of patients are significantly increased as
compared to the controls. Dialysis patients show a sig-
nificantly greater myocardial reflectivity and a reduced
homogeneity of distribution of gray levels (lower unifor-
mity) in comparison both with hypertensive patients and
normal controls. Multivariate analysis rules out that such
differences can be explained by gender, age, and body
surface area, all of them parameters not well balanced in
the three populations (Table 1).
To summarize, dialysis patients differed from hyper-
tensive patients for their VDT parameters but not for
IVS thickness, while hypertensive patients did not dif-
fer from healthy controls in VDT parameters in spite of
significantly higher IVS thickness (Table 2).
Left ventricular mass index in controls, hypertensive,
and dialysis patients was 97 ± 18 g/m2, 119 ± 23 g/m2, and
151 ± 41 g/m2, respectively, whichever comparison being
significant.
In the three categories of analyzed subjects none of the
VDT parameters shows any correlation with left ventric-
ular mass index, IVS thickness, or ejection fraction. On
the contrary, in dialysis patients we found a fairly good
correlation between early/atrial (E/A) diastole fillup and
reflectivity (r = 0.38, P = 0.003).
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Fig. 2. Correlation between age and reflectivity in normal subjects.
None of the VDT parameters was found to be signifi-
cantly different in dialysis patients with and without pre-
ceding cardiac infarcts. On the contrary, dialysis patients
with history of peripheral vascular disease showed, in
comparison with dialysis patients without, a significantly
higher reflectivity (110 ± 21 vs. 82 ± 15, respectively) (P <
0.001) and IVS thickness (13.7 ± 3.5 vs. 11.5 ± 2.2 mm)
(P < 0.001).
In the normal subjects we found a good correlation
between age and reflectivity (Fig. 2). This correlation dis-
appears in the dialysis patients in whom we found, on the
other hand, a slight correlation between reflectivity and
dialytic vintage (r = 0.23, P = 0.03).
In dialysis patients follow-up was 4.6 ± 2.9 years. Dial-
ysis patients with uniformity values above the median
showed a significantly longer survival than those with uni-
formity values below the median (Fig. 3). On the contrary,
the reflectivity was not predictive of all-cause mortality.
The adjusted hazard ratios with confidence intervals
(95% CI) for each covariate are given in Table 3.
DISCUSSION
The study by Bhandari and Nanda [18] was the first to
describe the characteristics of uremic myocardial tissue.
Using a qualitative approach, these authors found a pe-
culiar echo pattern characterized by the presence of very
bright or highly refractile echoes. Bhandari’s pioneering
study was subsequently confirmed by other researchers
[19–21].
Using a quantitative approach, other researchers were
able to confirm in dialysis patients a peculiar echo pattern
as compared to normal controls or hypertensive subjects
with normal renal function [22, 23].
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Present study was designed for the specific purpose
of ascertaining whether echocardiographic tissue analy-
sis can capture in vivo differences in the hypertrophic
myocardium between hypertensives with normal kid-
ney function and uremics in hemodialytic treatment, and
whether the ultrasonic alterations in the hypertrophic
uremic myocardium are independent risk factors for
survival.
Employing the VDT analysis we found that the echo
signals from the uremic heart appear different from those
of the hypertensive heart. In fact, compared with hy-
pertensives, dialysis patients show a significantly greater
myocardial reflectivity and a reduced homogeneity of
distribution of gray levels (lower uniformity) for com-
parable septum thickness. On the contrary, hyperten-
sive patients show VDT parameters similar to normal
control subjects in spite of significantly higher septum
thickness (Table 2). Thus, by means of a quantitative
observer-independent ultrasonic assessment, we have
demonstrated that the uremic myocardium shows high
refractile and inhomogeneous echoes. These abnormal-
ities seem peculiar to uremic myocardial hypertrophy
since they are not found in hypertensive subjects with
normal renal function and a comparable degree of IVS
hypertrophy.
In the uremic heart, some characteristics were found
microscopically [8, 9, 11] that are overexpressed in com-
parison with other types of LVH (e.g., cardiac hyper-
trophy resulting from hypertension not associated with
renal disease). It is tempting to speculate that these ab-
normalities, namely intermyocytic fibrosis and/or calcium
Table 3. Adjusted hazard ratios for all-cause mortality
Covariates HR 95% CI P value
Age (per year) 1.062 1.016–1.110 0.007
Cardiovascular comorbidity 2.837 1.318–6.106 0.008
Uniformity 2.521 1.207–5.268 0.014
Left ventricular mass index (per g/m2) 1.010 1.002–1.018 0.016
deposition, provide the anatomic basis for the changed
echo pattern in the uremic heart. Not having performed
cardiac biopsies, we lack direct evidence that might vali-
date this hypothesis. However, other studies have shown
that VDT parameters are influenced by the degree of
fibrosis present in the tissue examined [27] and our ear-
lier studies have provided indirect evidence of a possi-
ble association between alteration of VDT parameters
and calcium phosphorus metabolism in uremic patients
[24, 25]. However, the present study was not designed to
investigate the mechanisms underlying altered cardiore-
flectance, and that question thus remains open for later
studies.
It is legitimate to ask if the results we obtained are
simply a mirror of preceding myocardial infarcts and the
ensuing fibrotic scars. To eliminate such a possibility, we
excluded from the study patients with paradoxal move-
ment of the septum, a possible expression of previous
infarct in the site of VDT sampling. Moreover, we sub-
divided the dialytic population according to the presence
or absence of a preceding history of myocardial infarcts.
The fact that none of the VDT parameters differed in
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these two populations suggests that the previous cardiac
events do not account for the altered VDT values in the
dialysis patients.
The relation between reflectivity and a parameter of
diastolic dysfunction such as E/A ratio might indicate
that both parameters point to the same phenomenon, that
is, an altered myocardial structure that involves a minor
compliance of the left ventricle.
The association between alteration of VDT param-
eters and peripheral vasculopathy history agrees well
with a series of works on the role of arterial stiffness
in inducing cardiopathy [1, 3]. We evaluated vascular
damage only anamnestically both with clinical and instru-
mental parameters; we did not perform peripheral echo
color Doppler coincidentally with VDT analysis. We were
therefore unable to compare alterations in VDT with ob-
jective stiffness parameters such as pulse wave velocity.
This is one limitation of the work that may be covered by
later studies.
The positive correlation between calendar age and my-
ocardial hyperreflectivity in the controls disappears in the
dialysis patients, where on the contrary we found a slight
correlation between reflectivity and dialytic age, as if ure-
mia per se had obscured the natural association between
aging and VDT alterations. On these grounds, it is inter-
esting to note how VDT parameters in the 18 patients
in dialysis for less than 12 months are significantly more
compromised (reflectivity 85 ± 10, uniformity 135 ± 25)
than those found in normal subjects. These data seem to
indicate that myocardial structural alterations appear in
the early stages of chronic kidney disease; we are con-
ducting studies to gain more insight into this issue.
Although a note of caution should be expressed since
the study is borderline underpowered for survival analy-
sis, the most interesting result of our study is the find-
ing that VDT parameters are independent predictors
of mortality in dialysis patients. This result, to our best
knowledge, has never before been described. Indeed,
the mortality risk is about 2.5 times greater in patients
with reduced homogeneity of distribution of gray lev-
els. Lower uniformity values had independent prognos-
tic power over left ventricular mass index. We chose that
index because its association with mortality is well docu-
mented in the literature [1, 4, 5]. In reality, we derived
VDT indexes from the septum (i.e., from a muscular
component), while the left ventricular mass index is a
composite index based on both cavitary and muscular
components. However, when we entered IVS instead of
the left ventricular mass index in the Cox model, we ob-
tained a similar predictive value (RR 1.21, 95% CI 1.08-
1.35, per mm of IVS increase) (P = 0.001). We should
like to emphasize how in our study the predictivity of the
VDT parameters is similar to that found for cardiovascu-
lar comorbidity (e.g., a very hard predictor), while E/A
does not enter into our model.
We acknowledge some limitations peculiar to VDT
technique. Quantitative measurements of myocardial
structure by echocardiography can be affected by many
variables, such as general instrument gains and time gain
compensation curves. Thickness of the chest wall and dis-
tance of the heart from the transducer may differ be-
tween subjects and, therefore, affect VDT measurements.
Moreover, quantitative echocardiographic parameters
are dependent on the orientation of the echo reflectors
because the same target (region of interest) could pro-
duce different patterns depending on the view selected.
Last, but not least, different inclination of the transducer
between subjects, or between different exams in the same
subject, could also affect VDT measurements. To over-
come at least some of these drawbacks, we kept fixed
pre- and postprocessing echocardiographic settings. The
ensuing lower quality of images does not interfere with
the computerized gray level analysis.
CONCLUSION
In our study, the hypertensive heart differed from the
normal heart by the degree of hypertrophy but not in
terms of VDT parameters. By contrast, for similar degree
of LVH, dialysis patients differed widely in their VDT
parameters from hypertensives.
VDT parameters in dialysis patients did not correlate
with calendar age and did not depend on previous cardiac
events; instead they correlated with dialytic vintage, his-
tory of the peripheral vascular system disease, and E/A
ratio. Most important, VDT parameters were indepen-
dent predictors of all-cause mortality in dialysis patients.
Our experience indicates that myocardial quantitative
ultrasonic analysis appears to be a promising technique
for an observer-independent assessment of myocardial
tissue characteristics in dialysis patients. We feel that most
of the drawbacks potentially besetting VDT analysis can
be overcome if this technique is implemented serially on
the same patient.
APPENDIX. FIRST-ORDER STATISTICS:
QUANTITATIVE DEFINITIONS
By defining gij as the gray level of the pixel of coordinates (i, j) inside
the matrix of the region of interest R, and N the total number of gray
values, typical parameters extracted from the gray level distribution are
(1) the mean (m) reflectivity
1
N
∑
i, jeR
gij
which describes the average gray value of the distribution; (2) the stan-
dard deviation
√√√√ 1
N − 1
∑
i, jeR
(gij − m)2
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that is an expression of the spreading of the distribution from the mean
value, that is of the overall contrast; (3) the skewness
1
N
∑
i, jeR
(gij − m)3
( ∑
i, jeR
g2ij − m2
) 3
2
characterizing the deviation of the distribution from a symmetric refer-
ence one; positive values are for a left-skew distribution, while a skew-
ness to the right is classified by negative values; and (4) the curtosis
1
N
∑
i, jeR
(gij − m)4
( ∑
i, jeR
g2ij − m2
)2 − 3
which is related to the steepness of the distribution with respect to a
normal (Gaussian) distribution.
Furthermore, by defining pk(g) as the probability of the k-th gray
level, that is, the ratio between its frequency of occurrence and the total
number of pixels, two more first-order parameters can be introduced:
(1) the uniformity
256∑
k=2
p2k(g)
that is the level of tonal homogeneity; and (2) the entropy
−
256∑
k=2
pk(g) ln(pk(g))
a measurement of the level of disorder inside the gray level distribution
or the degree of tonal dishomogeneity. It is the reciprocal of unifor-
mity. Mathematically, it is the inverse of the natural logarithm of the
probabilities that the pixels cluster around a defined gray level.
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